Connecticut orthopedics maker Soft Tissue Regeneration is close to tying up a $5 million funding round.
Orthopedics maker Soft Tissue Regeneration is closing in on a $5 million funding round, with $4.7 million raised so far.
The New Haven, Conn.-based company is raising funds through sales of equity, options, warrants and other securities, with 14 unnamed investors listed so far in regulatory filings.
The company is working on products for soft tissue regeneration for knee ligaments using an FDA-approved polymer already common in medical implants.
STR in January won FDA clearance for its Str graft, a biodegradable scaffold that can lessen patient's pain and reduce surgical failure rates following rotator cuff surgery.
The FDA plans a public workshop on robotically-assisted surgical devices to solicit feedback on how...
Regdy blog's Andrew Ahn discusses the advantages of getting your device approved by FDA.
EndoChoice says it raised $57 million from a syndicate of prior and new backers it plans to use boost...
Europe's top court rules that Boston Scientific must cover the cost of replacing defective pacemakers...
Medtronic invests in anti-leg-cramp drug maker Flex Pharma's initial public offering.